Fight against breast cancer with innovative tests and biochips: Siemens Healthcare chooses Cologne as the new site for its molecular diagnostics research in Germany
Cologne - Siemens Healthcare has established new research laboratories for molecular diagnostics in Cologne, Germany. The focus of the research will be on “breast cancer”, a disease that remains the number one cause of death among young women despite the large number of therapies currently available. Almost 40 Siemens employees have been developing new diagnostic → Continue reading »
Subscribe
What is this?